| Literature DB >> 34789809 |
Soojin Park1, Dal Nim Lee1, Young Woo Jin1, Eun Shil Cha2, Won-Il Jang1,3, Sunhoo Park1,4, Songwon Seo5.
Abstract
Radiation-induced cancer risks have known stochastic effects; however, regarding non-cancer diseases, evidence of risk at low radiation doses remains unclear. We aimed to identify underlying characteristics concerning non-cancer disease prevalence and determine associations with radiation dose among Korean radiation workers. Using a nationwide baseline survey, 20,608 workers were enrolled. Data concerning participant demographics, occupational characteristics, lifestyle, and lifetime prevalence of non-cancer diseases were linked to a national dose registry. We compared non-cancer disease prevalences in the Korean general population with those in this cohort and undertook a dose-response analysis concerning the cumulative dose. Hyperlipidemia (10.6%), circulatory (9.6%), and respiratory (4.1%) system diseases, followed by thyroid diseases (3.5%), had the highest prevalences, with hyperlipidemia, thyroid diseases, and hepatitis prevalence being higher in the cohort than in the general population. Radiation doses were associated with elevated prevalences of most diseases; however, associations were attenuated and not significant after adjusting for confounders, except for musculoskeletal system diseases (prevalence odds ratio [POR]/10 mSv, 1.03; 95% confidence interval [CI] 1.00-1.07) and cataracts (POR/10 mSv, 1.04; 95% CI 1.00-1.07). Further studies are warranted to investigate the causality of those non-cancer diseases involving more varied confounders such as physical and psychosocial stresses and ultraviolet light.Entities:
Mesh:
Year: 2021 PMID: 34789809 PMCID: PMC8599676 DOI: 10.1038/s41598-021-01875-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Prevalence of non-cancer diseases in Korean radiation workers (n = 20,608).
| Diseases | Total | Men | Women | |||
|---|---|---|---|---|---|---|
| n | PR (%) | n | PR (%) | n | PR (%) | |
| 1855 | (9.6%) | 1801 | (10.8%) | 54 | (2.1%) | |
| Hypertension | 1759 | (9.3%) | 1709 | (10.4%) | 50 | (1.9%) |
| Stroke | 37 | (0.2%) | 31 | (0.2%) | 6 | (0.2%) |
| Myocardial infarction | 69 | (0.4%) | 64 | (0.4%) | 5 | (0.2%) |
| Angina | 103 | (0.5%) | 96 | (0.6%) | 7 | (0.3%) |
| 768 | (4.1%) | 654 | (4.0%) | 114 | (4.4%) | |
| Pulmonary tuberculosis | 386 | (2.0%) | 351 | (2.2%) | 35 | (1.3%) |
| Asthma | 287 | (1.5%) | 223 | (1.4%) | 64 | (2.5%) |
| Chronic bronchitis | 202 | (1.1%) | 162 | (1.0%) | 40 | (1.5%) |
| 184 | (1.0%) | 150 | (0.9%) | 34 | (1.3%) | |
| Rheumatoid arthritis | 114 | (0.6%) | 98 | (0.6%) | 16 | (0.6%) |
| Osteoporosis | 92 | (0.5%) | 68 | (0.4%) | 24 | (0.9%) |
| Thyroid diseasesa | 669 | (3.5%) | 501 | (3.1%) | 168 | (6.5%) |
| Hyperlipidemia | 2005 | (10.6%) | 1919 | (11.7%) | 86 | (3.3%) |
| Cataracts | 156 | (0.8%) | 141 | (0.9%) | 15 | (0.6%) |
| Diabetes mellitus | 563 | (3.0%) | 543 | (3.3%) | 20 | (0.8%) |
| Hepatitis | 322 | (1.7%) | 306 | (1.9%) | 16 | (0.6%) |
PR prevalence rate.
aIncluding benign thyroid tumor, thyroid nodule, thyroid goiter, thyroiditis, hyperthyroidism, and hypothyroidism.
Age- and sex-specific standardized prevalence ratios (SPRs).
| Diseases | Men | Women | Total | |||
|---|---|---|---|---|---|---|
| SPR | (95% CI) | SPR | (95% CI) | SPR | (95% CI) | |
| Diseases of the circulatory systema | 0.95 | (0.90–0.99) | 0.88 | (0.68–1.11) | 0.94 | (0.90–0.99) |
| Diseases of the respiratory systemb | 0.80 | (0.74–0.87) | 0.91 | (0.74–1.11) | 0.81 | (0.75–0.88) |
| Diseases of the musculoskeletal systemc | 0.73 | (0.62–0.85) | 0.51 | (0.36–0.69) | 0.67 | (0.58–0.77) |
| Thyroid diseasesd | 2.31 | (2.11–2.52) | 1.66 | (1.42–1.93) | 2.10 | (1.95–2.27) |
| Hyperlipidemia | 1.36 | (1.30–1.42) | 0.97 | (0.78–1.20) | 1.34 | (1.28–1.40) |
| Cataracts | 0.42 | (0.36–0.50) | 0.79 | (0.44–1.30) | 0.44 | (0.38–0.52) |
| Diabetes mellitus | 0.84 | (0.77–0.92) | 0.66 | (0.40–1.02) | 0.83 | (0.77–0.91) |
| Hepatitis | 1.20 | (1.07–1.34) | 0.80 | (0.46–1.29) | 1.17 | (1.04–1.30) |
CI confidence interval.
aIncluding hypertension, stroke, myocardial infarction, and angina.
bIncluding pulmonary tuberculosis and asthma.
cIncluding rheumatoid arthritis and osteoporosis.
dIncluding benign thyroid tumor, thyroid nodule, thyroid goiter, thyroiditis, hyperthyroidism, and hypothyroidism.
Prevalence odds ratios (PORs) per 10 mSv according to occupation and birth year.
| Adjusted PORa per 10 mSv (95% CI) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Diseases of the circulatory systemb | Diseases of the respiratory systemc | Diseases of the musculoskeletal systemd | Thyroid diseasese | Hyperlipidemia | Cataracts | Diabetes mellitus | Hepatitis | |
| Public institute | 1.05 (0.84–1.31) | 0.81 (0.38–1.73) | 0.64 (0.19–2.16) | 1.15 (0.82–1.61) | 1.00 (0.79–1.27) | 0.00 (0–113.65) | 1.27 (0.97–1.66) | 0.85 (0.48–1.53) |
| Education and research institute | 0.95 (0.73–1.23) | 0.93 (0.62–1.40) | 1.05 (0.63–1.74) | 0.66 (0.38–1.15) | 0.99 (0.76–1.28) | 0.85 (0.36–2.00) | 0.99 (0.68–1.43) | 1.05 (0.62–1.80) |
| Industrial radiography | 1.00 (0.96–1.05) | 0.99 (0.91–1.07) | 0.99 (0.83–1.19) | 0.88 (0.74–1.05) | 1.00 (0.95–1.04) | 0.91 (0.72–1.14) | 1.00 (0.93–1.09) | 0.93 (0.81–1.06) |
| Industry | 1.00 (0.84–1.17) | 1.01 (0.80–1.29) | 0.98 (0.52–1.83) | 0.96 (0.64–1.44) | 1.05 (0.91–1.22) | 1.33 (0.94–1.86) | 0.91 (0.67–1.24) | 1.12 (0.80–1.56) |
| Nuclear power plant | 1.00 (0.97–1.02) | 1.01 (0.97–1.04) | 1.05 (1.01–1.10) | 0.97 (0.93–1.00) | 1.01 (0.99–1.03) | 1.03 (0.99–1.08) | 1.01 (0.98–1.04) | 0.99 (0.95–1.03) |
| Medical institute | 0.92 (0.84–1.00) | 0.99 (0.88–1.11) | 1.09 (0.90–1.31) | 1.09 (0.98–1.21) | 0.95 (0.88–1.03) | 0.98 (0.72–1.32) | 0.99 (0.87–1.14) | 0.95 (0.76–1.17) |
| 1960 or earlier | 0.98 (0.95–1.01) | 1.00 (0.94–1.06) | 1.04 (0.98–1.11) | 1.01 (0.97–1.06) | 0.99 (0.96–1.02) | 1.06 (1.01–1.11) | 1.00 (0.97–1.04) | 1.00 (0.94–1.06) |
| 1961–1970 | 0.99 (0.96–1.02) | 1.01 (0.96–1.06) | 1.07 (1.00–1.13) | 0.90 (0.84–0.96) | 1.00 (0.98–1.03) | 0.94 (0.85–1.04) | 1.02 (0.99–1.06) | 0.95 (0.88–1.04) |
| 1971–1980 | 1.03 (0.99–1.07) | 1.03 (0.97–1.09) | 1.04 (0.94–1.15) | 0.99 (0.92–1.06) | 1.02 (0.99–1.06) | 1.11 (0.98–1.27) | 1.00 (0.93–1.07) | 1.02 (0.94–1.11) |
| 1981 or later | 1.03 (0.94–1.12) | 0.82 (0.70–0.96) | 0.74 (0.42–1.29) | 0.97 (0.82–1.15) | 1.01 (0.92–1.10) | 0.89 (0.59–1.34) | 0.90 (0.70–1.16) | 0.98 (0.83–1.15) |
CI confidence interval.
aPrevalence odds ratios were adjusted for sex, age, occupation, duration of employment, smoking status, alcohol status, regular exercise, body mass index, and night-shift work.
bIncluding hypertension, stroke, myocardial infarction, and angina.
cIncluding pulmonary tuberculosis and asthma.
dIncluding rheumatoid arthritis and osteoporosis.
eIncluding benign thyroid tumor, thyroid nodule, thyroid goiter, thyroiditis, hyperthyroidism, and hypothyroidism.